59 related articles for article (PubMed ID: 35795055)
1. Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer.
Yonemura Y; Elnemr A; Endou Y; Ishibashi H; Mizumoto A; Miura M; Li Y
Int J Surg Oncol; 2012; 2012():148420. PubMed ID: 22900159
[TBL] [Abstract][Full Text] [Related]
2. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.
Acs M; Piso P; Glockzin G
Curr Oncol; 2024 Mar; 31(3):1445-1459. PubMed ID: 38534942
[TBL] [Abstract][Full Text] [Related]
4. Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study.
Yang Z; Lu S; Shi M; Yuan H; Wang Z; Ni Z; He C; Zheng Y; Zhu Z; Liu W; Yao X; Zhang J; Li C; Yan M; Yan C; Zhu Z
Gastric Cancer; 2024 Mar; 27(2):387-399. PubMed ID: 38143257
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study.
Yang ZY; Yuan F; Lu S; Xu W; Wu JW; Xi WQ; Shi M; Wang ZQ; Ni ZT; He CY; Yao XX; Zheng YN; Zhu ZL; Liu WT; Zhang J; Zhang H; Li C; Yan C; Yan M; Zhu ZG
Front Oncol; 2022; 12():905922. PubMed ID: 35795055
[TBL] [Abstract][Full Text] [Related]
7. Benefits of Surgery After Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients With Peritoneal Metastasis: A Meta-Analysis.
Gong Y; Wang P; Zhu Z; Zhang J; Huang J; Wang T; Chen J; Xu H
J Surg Res; 2020 Jan; 245():234-243. PubMed ID: 31421368
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of conversion surgery after neoadjuvant intraperitoneal-systemic chemotherapy in treating peritoneal metastasis of gastric cancer.
Li Y; Lin H; Huang K; Zhao J
J BUON; 2021; 26(1):211-217. PubMed ID: 33721454
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.
Zhang X; Huang H; Yang D; Wang P; Huang X; Hu Z; Zhang Y; Yan R; Zhu Z; Cai Q
Technol Cancer Res Treat; 2021; 20():15330338211036310. PubMed ID: 34328799
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance and practice points of conversion therapy for gastric cancer with peritoneal metastasis].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1094-1098. PubMed ID: 29130218
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases.
Saito S; Yamaguchi H; Ohzawa H; Miyato H; Kanamaru R; Kurashina K; Hosoya Y; Lefor AK; Sata N; Kitayama J
Ann Surg Oncol; 2021 Jul; 28(7):3863-3870. PubMed ID: 33270170
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer.
Sah BK; Zhang B; Zhang H; Li J; Yuan F; Ma T; Shi M; Xu W; Zhu Z; Liu W; Yan C; Li C; Liu B; Yan M; Zhu Z
Nat Commun; 2020 Nov; 11(1):6093. PubMed ID: 33257672
[TBL] [Abstract][Full Text] [Related]
14. Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis.
Yang Z; Li C; Liu W; Zheng Y; Zhu Z; Hua Z; Ni Z; Lu S; Yan M; Yan C; Zhu Z
Chin J Cancer Res; 2020 Aug; 32(4):497-507. PubMed ID: 32963462
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
